Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 22, 2015 10:24 PM ET

Healthcare Providers and Services

Company Overview of Dana-Farber Cancer Institute, Inc.

Company Overview

Dana-Farber Cancer Institute, Inc. provides cancer treatment and research services for adults and children in the United States. It offers adult treatment and care services for blood, breast, cutaneous/skin, gastrointestinal, genitourinary, gynecological, head and neck, hematology, melanoma, neuro-oncology, sarcoma, and thoracic cancer; and cancer genetics and prevention services. The company also provides treatment and care for children with cancer, such as blood diseases, bone and soft tissue tumors, brain tumors, histiocytosis, Hodgkin lymphoma, kidney tumors, leukemia, neuroblastoma, non-Hodgkin lymphoma, and rare tumors program. In addition, it offers training in cancer treatment and re...

450 Brookline Avenue

Boston, MA 02215-5450

United States

Founded in 1947





Key Executives for Dana-Farber Cancer Institute, Inc.

Chief Executive Officer and President
Top Key
Age: 49
Chief Financial Officer and Assistant Treasurer
Chief Operating Officer and Executive Vice President
Age: 63
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2014.

Dana-Farber Cancer Institute, Inc. Key Developments

Midatech Pharma Announces Signature of a New Research Collaboration with Dana-Farber Cancer Institute

Midatech Pharma announced the signature of a new research collaboration with Dana-Farber Cancer Institute (Dana Farber). Under the terms of the collaboration, Midatech Pharma and Dana-Farber will test the preclinical effectiveness of Midatech's targeted nanomedicines against Glioblastoma (a type of brain cancer). The collaboration aims to find the most effective treatments to take into Glioblastoma patients as rapidly as possible, given the current unmet medical need. Gliobastoma represents approximately 17% of all primary brain tumors (about 60-75% of all astrocytomas) and is difficult to treat due to the involvement of different cell types.

Dana-Farber Cancer Institute, Inc. Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015

Dana-Farber Cancer Institute, Inc. Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Presentation Date & Speakers: Feb-23-2015, Barrett J. Rollins, MD, PhD, Chief Scientific Officer, O. Prem Das, Chief Business Development Officer.

Dana-Farber Cancer Institute, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Dana-Farber Cancer Institute, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
Evercare Hospice, Inc. United States
Independent Medical Supply Inc. United States
Convergence Services Group, LLC United States
Neapolitan Inpatient Care, LLC United States
Mary Free Bed Rehabilitation Hospital United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dana-Farber Cancer Institute, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at